vaccine trial participant
SII files Rs100 cr lawsuit after volunteer says Oxford vaccine left him ill
The Serum Institute of India has responded to "malicious and misconceived" allegations by preparing a Rs100 crore defamation suit against a Covishield coronavirus vaccine trial participant who claimed to suffer a "virtual neurological breakdown" after being administered a dose, reports NDTV.